Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA ...

The CIX Startup Awards is a showcase of Canada’s premier startups that are selected and recognized by North American investors. Award recipients will pitch in person this year at the CIX Summit on ...

PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today that ...

CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting antisense oligonucleotide (ASO) therapies to upregulate gene ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

Gene drive alleles bias their inheritance to spread through populations. Here, we constructed a moderate efficiency 2-gRNA nanos-Cas9 homing suppression drive in the malaria mosquito Anopheles ...

Reducing reliance on Earth-supplied feedstocks is crucial for advancing in-space biomanufacturing. Here, the authors explored three alternative feedstocks – Martian and Lunar regolith, post ...

Live webcasts of the Company’s presentations may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.

To access the live webcast of the presentation, please visit the “Events & Presentations” page of Revolution Medicines’ website at Additionally, a replay of the webcast will be available on the ...